📣 VC round data is live. Check it out!

Mirae Asset Securities Valuation Multiples

Discover revenue and EBITDA valuation multiples for Mirae Asset Securities and similar public comparables like China Securities, LPL Financial, China Merchants Securities, Futu Holdings and more.

Mirae Asset Securities Overview

About Mirae Asset Securities

Mirae Asset Securities Co Ltd is a South Korean financial service provider for individual and corporate customers. The company's services include securities trading, retail and wholesale brokerage, underwriting, dealing, investment advisory, asset management, international corporate finance, investment banking, and trading of fixed-income securities and derivatives. The company's financial products include stocks, futures, options, government bonds, corporate bonds, foreign exchange, and financial derivatives.


Founded

1970

HQ

South Korea

Employees

3.3K

Financials (LTM)

Revenue: $3B
Net Income: $1B

EV

$22B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Mirae Asset Securities Financials

Mirae Asset Securities reported last 12-month revenue of $3B.

In the same LTM period, Mirae Asset Securities generated $1B in net income.

Revenue (LTM)


Mirae Asset Securities P&L

In the most recent fiscal year, Mirae Asset Securities reported revenue of $2B and net income of $616M.

Mirae Asset Securities is profitable as of last fiscal year, with net margin of 29%.

See analyst estimates for Mirae Asset Securities
LTMLast FY202320242025202620272028
Revenue$3B$2B$1B$2B$3B
EBIT Margin55%49%
Net Profit$1B$616M$219M$616M$1B
Net Margin43%29%15%29%39%
Net Debt$13B

Financial data powered by Morningstar, Inc.

Mirae Asset Securities Stock Performance

Mirae Asset Securities has current market cap of $22B, and enterprise value of $22B.

Market Cap Evolution


Mirae Asset Securities' stock price is $38.32.

Mirae Asset Securities share price increased by 6.2% in the last 30 days, and by 334.0% in the last year.

Mirae Asset Securities has an EPS (earnings per share) of $1.06.

See more trading valuation data for Mirae Asset Securities
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$22B$22B-0.2%6.2%-4.9%334.0%$1.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Mirae Asset Securities Valuation Multiples

Mirae Asset Securities trades at 7.0x EV/Revenue multiple.

See NTM and 2027E valuation multiples for Mirae Asset Securities

EV / Revenue (LTM)


Mirae Asset Securities Financial Valuation Multiples

As of May 18, 2026, Mirae Asset Securities has market cap of $22B and EV of $22B.

Mirae Asset Securities has a P/E ratio of 16.4x.

LTMLast FY202320242025202620272028
EV/Revenue7.0x10.6x15.3x10.6x8.3x
EV/EBIT12.7x17.0x
P/E16.4x36.2x102.0x36.2x21.3x
EV/FCF(3.2x)(8.1x)(3.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Mirae Asset Securities Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Mirae Asset Securities Margins & Growth Rates

Mirae Asset Securities grew revenue by 28% and net profit by 76% in the last fiscal year.

In the most recent fiscal year, Mirae Asset Securities reported net margin of 29%.

See estimated margins and future growth rates for Mirae Asset Securities

Mirae Asset Securities Margins

Last FY202420252026202720282029
EBIT Margin49%61%
Net Margin29%29%39%45%
FCF Margin(328%)(328%)

Mirae Asset Securities Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth28%44%28%52%
EBIT Growth89%
Net Profit Growth76%182%70%74%
FCF Growth150%

Data powered by FactSet, Inc. and Morningstar, Inc.

Mirae Asset Securities Operational KPIs

Mirae Asset Securities' revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.4M for the same period.

Access forward-looking KPIs for Mirae Asset Securities
LTMLast FY202320242025202620272028
Revenue per Employee$0.6M
Opex per Employee$0.4M
S&M Expenses to Revenue6%7%6%
G&A Expenses to Revenue44%8%8%8%51%
Opex to Revenue62%76%62%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Mirae Asset Securities Competitors

Mirae Asset Securities competitors include China Securities, LPL Financial, China Merchants Securities, Futu Holdings, China Galaxy Securities, Shenwan Hongyuan, Daiwa Securities Group, Groww, Orient Securities and Guotai Haitong Securities.

Most Mirae Asset Securities public comparables operate across Investment Brokerage.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
China Securities10.2x11.0x
LPL Financial1.8x1.7x13.9x11.8x
China Merchants Securities9.9x10.6x
Futu Holdings6.5x6.2x10.3x10.0x
China Galaxy Securities7.8x8.3x
Shenwan Hongyuan8.7x9.3x
Daiwa Securities Group7.1x4.1x23.3x
Groww22.8x21.8x36.4x36.3x

This data is available for Pro users. Sign up to see all Mirae Asset Securities competitors and their valuation data.

Start Free Trial

Mirae Asset Securities Investment Activity

Mirae Asset Securities has invested in 2 companies to date.

Latest investment by Mirae Asset Securities was on February 9th 2026. Mirae Asset Securities invested in Galux in their $29M Series B round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Mirae Asset Securities

Galux
1st Biotherapeutics
Description
Galux is a Seoul-based biopharmaceutical firm utilizing AI-driven molecular design platforms to develop small-molecule drugs for rare diseases. The proprietary GALUX engine generates candidates for oncology and neurology targets, accelerating hit-to-lead optimization. Established in 2020, it advances multiple programs into preclinical stages.
1st Biotherapeutics is a Seoul-based biopharmaceutical company advancing first-in-class drug candidates for oncology and immunology. Its pipeline features small-molecule inhibitors targeting kinases, developed through in-house discovery platforms in medicinal chemistry and pharmacology. The firm collaborates with CROs in Korea, China, and the US for preclinical studies.
HQ CountrySouth KoreaSouth Korea
HQ City
Seoul
Deal Date9 Feb 202626 Jan 2026
RoundSeries BSeries D
Raised$29M$22M
InvestorsDayli Partners; InterVest Co.; Korea Development Bank; Korea Investment & Securities; Mirae Asset Securities; NCore Ventures; Pathway Partners; SL Investment; Snickpick Investment; Yuanta InvestmentANDA Asset Management; CKD Venture Capital Corporation; Dayli Partners; Gurum Investment Double Capital; Korea Investment & Securities; LigaChem Biosciences; Mirae Asset Securities; Smilegate Investment; Wanted Lab Partners; Woori Investment Bank
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Mirae Asset Securities investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Mirae Asset Securities

When was Mirae Asset Securities founded?Mirae Asset Securities was founded in 1970.
Where is Mirae Asset Securities headquartered?Mirae Asset Securities is headquartered in South Korea.
How many employees does Mirae Asset Securities have?As of today, Mirae Asset Securities has over 3K employees.
Who is the CEO of Mirae Asset Securities?Mirae Asset Securities' CEO is Mi-Seop Kim.
Is Mirae Asset Securities publicly listed?Yes, Mirae Asset Securities is a public company listed on Korea Exchange.
What is the stock symbol of Mirae Asset Securities?Mirae Asset Securities trades under 006800 ticker.
When did Mirae Asset Securities go public?Mirae Asset Securities went public in 1975.
Who are competitors of Mirae Asset Securities?Mirae Asset Securities main competitors include China Securities, LPL Financial, China Merchants Securities, Futu Holdings, China Galaxy Securities, Shenwan Hongyuan, Daiwa Securities Group, Groww, Orient Securities, Guotai Haitong Securities.
What is the current market cap of Mirae Asset Securities?Mirae Asset Securities' current market cap is $22B.
What is the current revenue of Mirae Asset Securities?Mirae Asset Securities' last 12 months revenue is $3B.
What is the current revenue growth of Mirae Asset Securities?Mirae Asset Securities revenue growth (NTM/LTM) is 20%.
What is the current EV/Revenue multiple of Mirae Asset Securities?Current revenue multiple of Mirae Asset Securities is 7.0x.
Is Mirae Asset Securities profitable?Yes, Mirae Asset Securities is net-income-positive (as of the last 12 months).
What is the current net income of Mirae Asset Securities?Mirae Asset Securities' last 12 months net income is $1B.
How many companies Mirae Asset Securities has acquired to date?Mirae Asset Securities hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Mirae Asset Securities has invested to date?As of May 2026, Mirae Asset Securities has invested in 2 companies.
What was the last Mirae Asset Securities investment?On 9th February 2026 Mirae Asset Securities invested in Galux, participating in a $29M Series B round, alongside Dayli Partners, InterVest Co., Korea Development Bank, Korea Investment & Securities, NCore Ventures, Pathway Partners, SL Investment, Snickpick Investment, and Yuanta Investment.
In what companies Mirae Asset Securities invested in?Mirae Asset Securities invested in Galux and 1st Biotherapeutics.

See public comps similar to Mirae Asset Securities

Lists including Mirae Asset Securities

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial